Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

February 29, 2016

Conditions
Extensive Stage Small Cell Lung CancerHealthy, no Evidence of DiseaseLimited Stage Small Cell Lung CancerRecurrent Non-small Cell Lung CancerRecurrent Small Cell Lung CancerStage IA Non-small Cell Lung CancerStage IB Non-small Cell Lung CancerStage IIA Non-small Cell Lung CancerStage IIB Non-small Cell Lung CancerStage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
Interventions
BEHAVIORAL

exercise intervention

Receive aerobic and exercise intervention

PROCEDURE

standard follow-up care

Receive usual care

PROCEDURE

quality-of-life assessment

Ancillary studies

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (2)

53715

UW Health Oncology - 1 South Park, Madison

53792

University of Wisconsin, Madison, Madison

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Wisconsin, Madison

OTHER

NCT01999881 - Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients | Biotech Hunter | Biotech Hunter